Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents

European Journal of Medicinal Chemistry

Volumn 38, Issue 9, 2003, Pages 791-800

  Jaso, Andrés ^a   Zarranz, Belén ^a   Aldana, Ignacio ^a   Monge, Antonio ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Anti Mycobacterium; Quinoxaline 1,4 dioxide; Tuberculosis

Indexed keywords

2 ACETYL 3 METHYL 7 METHOXYQUINOXALINE 1,4 DI N OXIDE; 2 ACETYL 3 METHYLQUINOXALINE 1,4 DI N OXIDE; 2 ACETYL 3,7 DIMETHYLQUINOXALINE 1,4 DI N OXIDE; 2 ACETYL 7 CHLORO 3 METHYLQUINOXALINE 1,4 DI N OXIDE; QUINOXALINE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; EVALUATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

EID: 0141953265     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(03)00137-5     Document Type: Article

References (27)

1. Snider D.E., Raviglione M., Kochi A. Global burden of tuberculosis. Bloom B. Tuberculosis: Pathogenesis, Protection and Control. 1994;3 ASM, Washington, DC.
2. Shinnick T.M., King C.H., Quinn F.D. Am. J. Med. Sci. 309:1995;92-98.
3. Snider D.E. Jr., La Montagne J.R. J. Infect. Dis. 169:1994;1189-1196.
4. Bass J.B. Jr., Farer L.S., Hopewell P.C., O'Brien R., Jacobs R.F., Ruben F., Snider D.E. Jr., Thornton G. Am. J. Respir. Crit. Care Med. 149:1994;1359-1374.
5. Pathak A.K., Pathak V., Seitz L., Maddry J.A., Gurcha S.S., Besra G.S., Suling W.J., Reynolds R.C. Bioorg. Med. Chem. 9:2001;3129-3143.
6. G.W.H. Cheeseman, R.F. Cookson, in: A. Weissberger, E.C. Taylor (Eds.), The Chemistry of Heterocyclic Compounds, Vol. 35, Wiley, New York, 1979, pp. 1-27, 35-38.
7. Porter A.E.A. Katrizky A.R., Rees C.W. Comprehensive Heterocyclic Chemistry. 3:1984;157-197 Pergamon Press, New York.
8. Carter G.A., Clark T., James C.S., Loeffler R.S.T. Pestic. Sci. 14:1983;135-144.
9. Sanna P., Carta A., Loriga M., Zanetti S., Sechi L. Il Fármaco. 54:1999;169-177.
10. Dirlam J.P., Presslitz J.E., Williams B.J. J. Med. Chem. 26:1983;1122-1126.
11. Musatova I.S., Elina A.S., Padeiskaya E.N., Shipilova L.D., Yakobson G.G., Furin G.G. Khim. Farm. Zh. 16:1982;934-938.
12. Musatova I.S., Elina A.S., Padeiskaya E.N. Khim. Farm. Zh. 16:1982;1063-1067.
13. A. Monge, M.J. Gil, M.A. Pascual, M.A. Gastelurrutia, Ann. R. Acad. Farm. 49 (1983) 37-47 [Chem. Abst. 99 (1983) 194924s].
14. Monge A., Gil M.J., Pascual M.A. Ann. R. Acad. Farm. 49:1983;199-209.
15. J.D. Johnston, US Patent 3,344,022 (1967).
16. R.H.B. Galt, US Patent 3,479,354 (1969).
17. W. Schmid, Switz. Patent CH 630,908 (1982).
18. Monge A., Palop J.A., López de Cerain A., Senador V., Martínez-Crespo F.J., Sainz Y., Narro S., García E., de Miguel C., González M., Hamilton E., Barker A.J., Clarke E.D., Greenhow D.T. J. Med. Chem. 38:1995;1786-1792.
19. Ortega M.A., Sainz Y., Montoya M.E., et al. Die Pharm. 54:1999;24-25.
20. Sainz Y., Montoya M.E., Martínez-Crespo F.J., et al. Arzneim.-Forsch./Drug Res. 49:1999;55-59.
21. Montoya M.E., Sainz Y., Ortega M.A., et al. Organización Farmacéutica Ibero-Latinoamericana (OFIL). 8:1998;36-41.
22. Montoya M.E., Sainz Y., Ortega M.A., et al. Il Farmaco. 53:1998;570-573.
23. Ortega M.A., Sainz Y., Montoya M.E., Jaso A., Zarranz B., Aldana I., Monge A. Arzneim. Forsch./Drug Res. 52:2002;113-119.
24. Ortega M.A., Morancho M.J., Martínez-Crespo F.J., et al. Eur. J. Med. Chem. 35:2000;21-30.
25. Collins L.A., Franzblau S.G. Antimicrob. Agents Chemother. 41:1997;1004-1009.
26. Skinner P.S., Furney S.K., Jacobs M.R., et al. Antimicrob. Agents Chemother. 38:1994;2557-2563.
27. Franzblau S.G., Cook M.B., Quenzer V.K., Ferguson R.M., Gilman R.H. J. Clin. Microbiol. 36:1998;362.